MedTrace Logo

Vitamin D Supplementation and PTH Response Among Malaysian Adults

NCT05281107 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2022-03-16

No results posted yet for this study

Summary

This clinical trial was designed to determine the efficacy of vitamin D supplementation on plasma 25-hydroxyvitamin D \[25(OH)D\] and intact parathyroid hormone (PTH) concentrations of Malaysian female adults of child-bearing age after daily intake of vitamin D supplements containing either 0 IU, 600 IU, 1200 IU or 4000 IU vitamin D for 16 weeks.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Placebo, 500 mg calcium

Berry flavoured sachet powder (500 mg calcium)

DIETARY_SUPPLEMENT

600 IU vitamin D + 500 mg calcium

Berry flavoured sachet powder (600 IU vitamin D + 500 mg calcium)

DIETARY_SUPPLEMENT

1200 IU vitamin D + 500 mg calcium

Berry flavoured sachet powder (1200 IU vitamin D + 500 mg calcium)

DIETARY_SUPPLEMENT

4000 IU vitamin D + 500 mg calcium

Berry flavoured sachet powder (4000 IU vitamin D + 500 mg calcium)

Sponsors & Collaborators

  • IMU University, Malaysia

    lead OTHER

Principal Investigators

  • Geok Lin Khor · IMU University, Malaysia

  • Megan Chong · IMU University, Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-10
Primary Completion
2016-09-26
Completion
2016-10-01

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05281107 on ClinicalTrials.gov